Surface Logix Commences Phase 2a Clinical Trial of SLx-2101 in Raynaud's Disease.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    PR Newswire. 2007.